Cipher Pharmaceuticals to Present at Two Upcoming Investor Conferences

MISSISSAUGA, ON, March 3, 2016 /CNW/ - Cipher Pharmaceuticals Inc. (NASDAQ:CPHR; TSX:CPH) ("Cipher" or "the Company") today announced that Shawn Patrick O'Brien, President and Chief Executive Officer, will present at two upcoming investor conferences.

• The 36th Annual Cowen and Company Health Care Conference in Boston on March 8, 2016
  at 9:15 a.m. ET.
• The 28th Annual ROTH Conference in Orange County on Tuesday, March 15, 2016
  at 3:30 p.m. PT.

Both conference presentations will be webcast live. To access the webcasts, please go to the Investors section of the Company's website at www.cipherpharma.com under the Events & Webcasts tab. 

About Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals (NASDAQ:CPHR; TSX:CPH) is a rapidly growing specialty pharmaceutical dermatology company with a diversified portfolio of commercial-stage products with the goal of becoming the most customer-centric dermatology company in North America.

Cipher completed seven transactions in 2015, including the acquisition of Innocutis and its nine branded dermatology products, to build its U.S. commercial presence, expand its Canadian dermatology franchise and broaden its pipeline. Cipher is well-capitalized to drive long-term, sustained earnings growth by leveraging its proven clinical development capabilities and efficient commercial execution. For more information, visit www.cipherpharma.com.

SOURCE Cipher Pharmaceuticals Inc.

Investors: In Canada: Craig Armitage, LodeRock Advisors, [phone], [email protected]; In the United States: Thomas Hoffmann, The Trout Group LLC, [phone], [email protected]; Media: Mike Beyer, Sam Brown Inc., [phone], [email protected]